COR:NYSE
Cencora Inc
US$314,59
arrow_downward
-0,11%(-0,34) 1D
6 ຕ.ລ., 14 ໂມງ 51 ນາທີ 21 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COR...
Open
US$314,63
High
US$316,14
Low
US$311,83
Mkt. cap
13,90 ຕື້
Avg. vol.
1,26 ລ້ານ
Volume
319,46 ພັນ
52-wk high
US$377,54
52-wk low
US$244,82
Beta
0,58
Shares outstanding
190,83 ລ້ານ
No. of employees
49 ພັນ
Open
US$314,63
High
US$316,14
Low
US$311,83
Mkt. cap
13,90 ຕື້
Avg. vol.
1,26 ລ້ານ
Volume
319,46 ພັນ
52-wk high
US$377,54
52-wk low
US$244,82
Beta
0,58
Shares outstanding
190,83 ລ້ານ
No. of employees
49 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
·
3 ຊົ່ວໂມງກ່ອນ
Cencora stock carries an 18.2 percent analyst upside
Investing.com Canada
·
8 ຊົ່ວໂມງກ່ອນ
Form 4 Cencora Inc For: 6 October By Investing.com
Stock Titan
·
20 ຊົ່ວໂມງກ່ອນ
A 275-share stock grant for Cencora (COR) director Robert E. Sanchez vests in one year.
News Corp
·
22 ຊົ່ວໂມງກ່ອນ
Cencora Inc. stock outperforms competitors on strong trading day
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc